rs140596058
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001029896.2(WDR45):c.351C>T(p.Ile117=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00205 in 1,210,619 control chromosomes in the GnomAD database, including 3 homozygotes. There are 720 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0010 ( 0 hom., 32 hem., cov: 24)
Exomes 𝑓: 0.0022 ( 3 hom. 688 hem. )
Consequence
WDR45
NM_001029896.2 synonymous
NM_001029896.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.414
Genes affected
WDR45 (HGNC:28912): (WD repeat domain 45) This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. This gene has a pseudogene at chromosome 4q31.3. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene, but the biological validity and full-length nature of some variants have not been determined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
?
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
?
Variant X-49076515-G-A is Benign according to our data. Variant chrX-49076515-G-A is described in ClinVar as [Benign]. Clinvar id is 383408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-49076515-G-A is described in Lovd as [Likely_benign]. Variant chrX-49076515-G-A is described in Lovd as [Benign].
BP7
?
Synonymous conserved (PhyloP=-0.414 with no splicing effect.
BS1
?
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00102 (115/112577) while in subpopulation NFE AF= 0.00178 (95/53262). AF 95% confidence interval is 0.00149. There are 0 homozygotes in gnomad4. There are 32 alleles in male gnomad4 subpopulation. This position pass quality control queck.
BS2
?
High Hemizygotes in GnomAd at 32 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
WDR45 | NM_001029896.2 | c.351C>T | p.Ile117= | synonymous_variant | 6/11 | ENST00000376372.9 | |
WDR45 | NM_007075.4 | c.354C>T | p.Ile118= | synonymous_variant | 7/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
WDR45 | ENST00000376372.9 | c.351C>T | p.Ile117= | synonymous_variant | 6/11 | 1 | NM_001029896.2 | P4 |
Frequencies
GnomAD3 genomes ? AF: 0.00102 AC: 115AN: 112524Hom.: 0 Cov.: 24 AF XY: 0.000923 AC XY: 32AN XY: 34672
GnomAD3 genomes
?
AF:
AC:
115
AN:
112524
Hom.:
Cov.:
24
AF XY:
AC XY:
32
AN XY:
34672
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000895 AC: 164AN: 183314Hom.: 0 AF XY: 0.000812 AC XY: 55AN XY: 67768
GnomAD3 exomes
AF:
AC:
164
AN:
183314
Hom.:
AF XY:
AC XY:
55
AN XY:
67768
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00216 AC: 2371AN: 1098042Hom.: 3 Cov.: 31 AF XY: 0.00189 AC XY: 688AN XY: 363422
GnomAD4 exome
AF:
AC:
2371
AN:
1098042
Hom.:
Cov.:
31
AF XY:
AC XY:
688
AN XY:
363422
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.00102 AC: 115AN: 112577Hom.: 0 Cov.: 24 AF XY: 0.000921 AC XY: 32AN XY: 34735
GnomAD4 genome
?
AF:
AC:
115
AN:
112577
Hom.:
Cov.:
24
AF XY:
AC XY:
32
AN XY:
34735
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 07, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Neurodegeneration with brain iron accumulation 5 Benign:2
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 21, 2024 | - - |
Likely benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Mar 30, 2018 | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 27, 2017 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
Cadd
Benign
Dann
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at